While those activities are sure to play a role, recent in vivo data showing that a transactivation-deficient form of p53 (mutated in both transactivation domains, TAD1 and TAD2) fails to inhibit tumor formation firmly establishes that the transcriptional activity of p53 is essential for tumor suppression [16,17]. This evidence concerns the gene TP53 and neoplasm.